Vixiar Medical recently closed a $1.5 million financing round and is preparing for regulatory submissions and then commercial launch. Local investors included TEDCO and the Abell Foundation. “We are very excited about The LaunchPort™ concept and the services it brings us at this stage of our development,” said Kevin Thibodeau, CEO of Vixiar. “We are also committed to bringing jobs to the City of Baltimore and contributing to the growth of a robust medical technology community in the State of Maryland.” Vixiar will maintain an existing business development office in Anne Arundel County.
Robert Storey, Managing Partner of The LaunchPort™ said, “We are excited to have Vixiar join us, as they are representative of the emerging high value medical technologies that the State and its institutions are capable of producing.” He concluded, “This moves us forward towards our strategy of growing and anchoring medical technology manufacturing within the city of Baltimore”.
The LaunchPort™ is a second stage accelerator for medical technology companies that are nearing or have recently completed regulatory approval. It offers a full range of production capabilities that enable emerging growth companies to efficiently launch their products into the market.